U.S. National Telemedicine debuts telehealth service DocTalkGo
Category: #business  By Mateen Dalal  Date: 2019-07-31
  • share
  • Twitter
  • Facebook
  • LinkedIn

U.S. National Telemedicine debuts telehealth service DocTalkGo

DocTalkGo is a third-party tool which provides various telemedicine healthcare options in the U.S.

Sole telemedicine weight loss entity of U.S. has recently launched a telehealthcare service dubbed DocTalkGo. According to sources, the platform aims to treat a wide range of health conditions with the help of virtual specialists, doctors and nurses.

For the record, Telehealth service, also known as Telemedicine, is a promising and a fast-paced industry that allows patients and doctors to connect on a remote basis for treatment, diagnosis and management of a growing number of health issues ranging from weight loss, to acne treatment, to birth control and much more.

Sources claim that telemedicine-based health systems make it convenient for consumers to access basic healthcare services, eliminating the need for in-person visits, provide access to doctors and nurses outside of typical office hours, eliminate long wait times and further reduce the cost for both patients and doctors. 

As for DocTalkGo, it is a HIPPA compliant service with years of experience in the telemedicine/telehealth sector. Patients can have their medicines prescribed and shipped to their address through partnered pharmacies for convenience and privacy.

Some of the services provided by DocTalkGo include long term management of dermatology, skin disorders, diabetes, obesity treatment, high blood pressure, infections, anemia, STD treatment, cardiovascular disease and hormone replacement therapy. 

Seemingly, these consultations are either done on phones or on video after the patient has filled their online health screening and consent forms. These types of sessions are not appropriate for patients requiring a physical examination.

Reliable reports cite that DocTalkGo has developed an algorithm that helps customers to go through various healthcare screening questions to determine if that specific healthcare issue is appropriate for telemedicine care or should it be reverted to an in-person doctor visit.

Moreover, DocTalkGo healthcare providers can also conduct nationwide laboratory tests and medicine submission to a pharmacy of the patient’s choice.

Source Credit: https://www.globenewswire.com/news-release/2019/07/30/1893339/0/en/National-Telemedicine-Company-Launches-DocTalkGo-Platform-With-Licensed-Medical-Experts-On-Demand.html

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal    

Mateen Dalal

Mateen has completed his Bachelor’s degree in electronics and telecommunication engineering, post which he lent his proficiency to the industry, working as a quality and test engineer. Drawn intricately toward the field of content creation however, Mateen soon switc...

Read More

More News By Mateen Dalal

MoA Technology targets herbicide resistance crisis & raises $8 million
MoA Technology targets herbicide resistance crisis & raises $8 million
By Mateen Dalal

MoA Technology has created three platforms: MoA SELECTTM, MoA TARGETTM and MoA GALAXYTM, which would work together for effective herbicide creation.   MoA Technology is borne out of Oxford University research is aimed at inhibiting herbicide...

Trump refuses to forge deals with Huawei citing national security
Trump refuses to forge deals with Huawei citing national security
By Mateen Dalal

Donald Trump declares the business with Huawei as a national threat and hence forth has declined all the business opportunities with the company.   The existing contract of the Commerce Department is expected to end sooner. The United Stat...

Trovagene to unveil key study data at APAC Prostate Cancer Conference
Trovagene to unveil key study data at APAC Prostate Cancer Conference
By Mateen Dalal

Data from the Phase 2 Onvansertib clinical trial will be presented at the 20th Prostate Cancer Conference.   The trial assesses the efficacies of Onvansertib on patients with Metastatic Castration-Resistant Prostate Cancer. Trovagene, a cl...